These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 789027)

  • 1. S-carboxymethylcysteine in the fluidification of sputum and treatment of chronic airway obstruction.
    Edwards GF; Steel AE; Scott JK; Jordan JW
    Chest; 1976 Oct; 70(4):506-13. PubMed ID: 789027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No demonstrable effect of S-carboxymethylcysteine on clearance of secretions from the human lung.
    Thomson ML; Pavia D; Jones CJ; McQuiston TA
    Thorax; 1975 Dec; 30(6):669-73. PubMed ID: 769242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in sputum in catarrhal bronchitis in children after treatment with S-carboxymethylcysteine (viscosimetric studies)].
    Castello D; Costa G; De Candussio G
    Minerva Pediatr; 1979 Mar; 31(5):371-80. PubMed ID: 460097
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of S-carboxymethylcysteine on the biophysical and biochemical properties of mucus in chronic bronchitics.
    Cox A; Jabbal-Gill I; Marriott C; Davis SS
    Adv Exp Med Biol; 1982; 144():423-9. PubMed ID: 7080939
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of S-carboxymethylcysteine on tracheal mucus velocity.
    Goodman RM; Yergin BM; Sackner MA
    Chest; 1978 Dec; 74(6):615-8. PubMed ID: 367726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the mucoregulator S-carboxy-methyl-cysteine in patients with chronic bronchitis.
    Puchelle E; Aug F; Polu JM
    Eur J Clin Pharmacol; 1978 Nov; 14(3):177-84. PubMed ID: 365537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies of the clinical effectiveness of the mucolytic drug, S-carboxymethylcysteine, in the therapy of acute and chronic bronchitis].
    Magliulo E; Bonizzoni D; Cattaneo E; Scevola D; Concia E
    Minerva Med; 1975 Apr; 66(25):1187-97. PubMed ID: 1134660
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the elastic and viscous components of bronchial mucus before and after S-carboxymethylcysteine-Lys treatment.
    Braga PC; Bossi R; Allegra L
    Int J Clin Pharmacol Res; 1984; 4(2):121-7. PubMed ID: 6469438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic behavior of S-carboxymethylcysteine-Lys in patients with chronic bronchitis.
    Braga PC; Borsa M; De Angelis L; Bossi R; Allegra L; Scaglione F; Scarpazza G
    Clin Ther; 1982; 4(6):480-8. PubMed ID: 7093981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Optimal use of expectorants (current trends)].
    Mirrakhimov MM; Brimkulov NN; Rafibekova ZhS
    Ter Arkh; 1981; 53(1):110-7. PubMed ID: 7013137
    [No Abstract]   [Full Text] [Related]  

  • 11. A between-patient, double-blind comparison of S-carboxymethylcysteine and bromhexine in chronic obstructive bronchitis.
    Aylward M
    Curr Med Res Opin; 1973; 1(4):219-27. PubMed ID: 4589629
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of erdosteine, a mucolytic agent, on amoxycillin penetration into sputum in patients with an infective exacerbation of chronic bronchitis.
    Ricevuti G; Mazzone A; Uccelli E; Gazzani G; Fregnan GB
    Thorax; 1988 Aug; 43(8):585-90. PubMed ID: 3051508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term oral carbocisteine therapy in patients with chronic bronchitis. A double blind trial with placebo control.
    Grillage M; Barnard-Jones K
    Br J Clin Pract; 1985 Oct; 39(10):395-8. PubMed ID: 3907681
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical therapeutic evaluation of methylcysteine hydrochloride in patients with chronic obstructive bronchitis: a balanced double-blind trial with placebo control.
    Aylward M; Bater PA; Davies DE; Hutchings LA; Lewis PA; Maddock J; Protheroe DA
    Curr Med Res Opin; 1978; 5(6):461-71. PubMed ID: 350498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of oral acetylcysteine (Fabrol) in chronic bronchitis: a double-blind placebo controlled study.
    Jackson IM; Barnes J; Cooksey P
    J Int Med Res; 1984; 12(3):198-206. PubMed ID: 6376210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambroxol for the prevention of chronic bronchitis exacerbations: long-term multicenter trial. Protective effect of ambroxol against winter semester exacerbations: a double-blind study versus placebo.
    Olivieri D; Zavattini G; Tomasini G; Daniotti S; Bonsignore G; Ferrara G; Carnimeo N; Chianese R; Catena E; Marcatili S
    Respiration; 1987; 51 Suppl 1():42-51. PubMed ID: 3299567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-carboxymethylcysteine in the treatment of glue ear: a double blind trial.
    Ramsden RT; Moffat DA; Gibson WP; Jay MM
    J Laryngol Otol; 1977 Oct; 91(10):847-51. PubMed ID: 336818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mucodine in the treatment of chronic bronchitis].
    Wierzbicka M; Wójcik RA
    Pneumonol Pol; 1981; 49(5):369-76. PubMed ID: 7022385
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of long term treatment with oxitropium bromide on airway secretion in chronic bronchitis and diffuse panbronchiolitis.
    Tamaoki J; Chiyotani A; Tagaya E; Sakai N; Konno K
    Thorax; 1994 Jun; 49(6):545-8. PubMed ID: 8016790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the activity of the carbocysteine-sobrerol combination on mucus spinnability.
    Distefano SM; Palermo F; Crimi N; Mistretta A; Pamparana F; Messa A
    Int J Clin Pharmacol Res; 1988; 8(1):31-5. PubMed ID: 3284830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.